Venus Concept Inc. (NASDAQ:VERO – Get Rating) Director Anthony Natale sold 51,428 shares of the firm's stock in a transaction that occurred on Monday, November 28th. The shares were sold at an average price of $0.27, for a total value of $13,885.56. Following the transaction, the director now directly owns 692,938 shares of the company's stock, valued at approximately $187,093.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Anthony Natale also recently made the following trade(s):

• On Friday, November 25th, Anthony Natale sold 51,428 shares of Venus Concept stock. The stock was sold at an average price of $0.31, for a total value of $15,942.68.
• On Tuesday, November 22nd, Anthony Natale sold 51,428 shares of Venus Concept stock. The stock was sold at an average price of $0.20, for a total value of $10,285.60.

Venus Concept Stock Performance

VERO stock opened at $0.24 on Thursday. The company has a market cap of $16.21 million, a P/E ratio of -0.41 and a beta of 1.80. Venus Concept Inc. has a 1 year low of $0.15 and a 1 year high of $2.21. The company has a debt-to-equity ratio of 7.75, a current ratio of 2.74 and a quick ratio of 1.92. The stock's fifty day moving average price is $0.29 and its 200-day moving average price is $0.47.

Institutional Investors Weigh In On Venus Concept

Large investors have recently added to or reduced their stakes in the stock. Essex Investment Management Co. LLC purchased a new stake in shares of Venus Concept in the first quarter valued at approximately $55,000. Bank of New York Mellon Corp boosted its stake in shares of Venus Concept by 140.2% during the 1st quarter. Bank of New York Mellon Corp now owns 86,578 shares of the company's stock worth $124,000 after acquiring an additional 50,530 shares in the last quarter. HighTower Advisors LLC purchased a new stake in shares of Venus Concept during the 1st quarter worth about $31,000. Vanguard Group Inc. lifted its stake in Venus Concept by 2.3% in the 1st quarter. Vanguard Group Inc. now owns 1,121,558 shares of the company's stock valued at $1,603,000 after buying an additional 25,630 shares in the last quarter. Finally, Prelude Capital Management LLC lifted its stake in Venus Concept by 73.4% in the 1st quarter. Prelude Capital Management LLC now owns 177,246 shares of the company's stock valued at $253,000 after buying an additional 75,000 shares in the last quarter. 51.05% of the stock is owned by institutional investors.

About Venus Concept

(Get Rating)

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.

Featured Articles

• Get a free copy of the StockNews.com research report on Venus Concept (VERO)
• La-Z-Boy Reclines To More Comfortable Levels
• Is Apple Going To Rally Into Year End?
• Is The Recovery Rally Here For SoFi?
• Will Easing Of Covid Rules Slash Risk For Chinese EV Maker NIO?
• Santa Claus Rally? Here's What Needs to Happen

Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.